WA Biotech Boom: Reliis and NovaCina’s Perfect Partnership
NovaCina is proud to collaborate with Reliis Limited, an emerging biotech company, in Western Australia’s dynamic life sciences sector. This partnership exemplifies the state’s entrepreneurial spirit, traditionally seen in the mining industry, now flourishing in new fields like BioTech and MedTech. Our collaboration with Reliis,…
read more
Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board
We are pleased to announce the appointment of John Van Der Wielen to our Board of Directors. His extensive accomplishments in corporate strategy across diverse industries, including the health industry, plus his proven track record of driving growth and innovation, makes him a valuable asset…
read more
Exciting News: NovaCina’s President, Brett Alderson, Featured on Molecule to Market Podcast!
We are thrilled to announce that our very own Brett Alderson, President and Site Leader of NovaCina, was recently featured on the Molecule to Market podcast hosted by Raman Sehgal. In this engaging episode, Brett delves into becoming a CDMO within the global drug development…
read more
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision
Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors (Miami and Perth, Australia, March 5, 2024) Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced today the appointment of Mark W. Womack as a…
read more